PATENT CLAIM ANALYSIS

Application Number: 15903738
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "058000"]

Abstract:
Pharmaceutical composition and their uses are disclosed, the composition comprising at least one methyl cyclodextrin having a molar substitution (MS) degree of between 0.05 and 1.5 in the treatment and/or prevention of diseases that can be treated and/or prevented by an increase in the HDL cholesterol level.

Claim (Index 12):
A method of treating diseases of the central nervous system, comprising administrating a pharmaceutical composition comprising at least one methyl cyclodextrin having a degree of molar substitution between 0.05 and 1.5 to a subject having diseases of the central nervous, increasing the level of HDL in the subject and thereby reducing at least one of overload, storage and accumulation of cholesterol in the tissues of the central nervous system.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 88.0
- Lexical Diversity: 1.15909
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15288876', '14442637', '14737473', '14913978', '14391236']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7218985711532022
- 35 USC 102 Novelty (BERT): 0.5044094793004612
- Combined Prediction Score: 0.7001496619679282
- Mean Citation Score: 211.46352
- Max Citation Score: 222.21622
- Similarity Product: 138.41475034893273

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test